Proposed Issue of Securities — IBX

Jul 29, 2020
Posted in: News, Investor updates

Home » Proposed Issue of Securities — IBX

Proposed Issue of Securities — IBX

Jul 29, 2020
Posted in: News, Investor updates

Imagion Biosystems Limited has announced a Proposed Issue of Securities.

10 Things to Know About MagSense®, Part 1: Why the Imaging Market Needs MagSense

October 22, 2026

Bringing molecular specificity to MRI could change the way cancer is diagnosed. We’re proud of the first-of-its-kind technology behind MagSense®, but breakthrough technology alone does

The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging

October 17, 2026

Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the

The Unanswered Question in Prostate Cancer Diagnosis

September 24, 2026

Separating lethal disease from indolent disease remains the persistent difficulty, and molecular MRI may offer a way to see the difference. Prostate cancer is the

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Proposed Issue of Securities — IBX

Proposed Issue of Securities — IBX

Related Articles

10 Things to Know About MagSense®, Part 1: Why the Imaging Market Needs MagSense

The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging

The Unanswered Question in Prostate Cancer Diagnosis

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list